Stock Groups

What to know about the COVID-19 vaccine for U.S. children -Breaking


© Reuters. FILEPHOTO: This illustration was taken October 30, 2020. REUTERS/Dado Ruvic/File Photo

By Michael Erman

NEW YORK (Reuters] – A COVID-19 vaccine is being considered by the U.S. Food and Drug Administration for children aged five to eleven years. The vaccine is from Pfizer Since May, Inc (NYSE:), and BioNTech Se (NASDAQ:), are available to children aged 12-15 in the United States.

This is all you need to know regarding vaccines and children.

What date will COVID-19 vaccinations become available to 5- and 11-year olds?

They will likely be available in November. Following Tuesday’s meeting, FDA will examine the recommendation from a panel of experts and approve the vaccine. It is expected to do so within days. After a meeting of experts from the U.S. Centers for Disease Control and Prevention, the CDC director will take the final decision.

Are there any shots available?

It all depends on where you live, whether it’s in schools or pharmacies.

Does it contain the same vaccination as the one for adults?

Yes. But at a lower dosage. Pfizer, BioNTech and others have requested authorization for a 10-microgram vaccine. This is a third dose that would be given to adults 12 years and over. It is still two shots, and the doses are given approximately three weeks apart.

How do I know if my child’s age is between a 5-year-old and a 10-year-old? Do they need to get their doses?

Brittany Kmush is an epidemiologist at Syracuse University and a professor of medicine. The dosage depends on the patient’s age, not their weight. She explained that vaccinations have a different dosing strategy than medications. This has more to do the maturation of the immune system than it does with weight and metabolism.

It is it safe?

The safety data for more than 3000 children who were vaccinated in the 4,500-person clinical trial by Pfizer was comparable to those of 16-to-25-year-olds. Fever, headaches and colds were the most frequent side effects in children. These symptoms are less common and more mild than those reported for 12 to 15 year-olds.

Pfizer/BioNTech both Moderna (NASDAQ:) Inc vaccines were linked to myocarditis in rare instances, particularly among young men.

Pfizer said that myocarditis rates in this age group are likely to be less than in those vaccinated 12-15-year-olds. This is due to the reduced dose.

It works?

BioNTech and Pfizer said that their COVID-19 vaccine inducing strong immune responses in 5-year-olds to 11-year olds during clinical trials last month. In the same study, the vaccine also showed a 90.7% effectiveness against COVID-19.

Why bother vaccination if children are less likely get COVID-related serious illness?

The public health tool of pediatric vaccination to protect children from infectious diseases is vital. The United States has vaccines available for children who are susceptible to illnesses such as chickenpox and rubella.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this website’s data including quotes, charts and sell/buy signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.